Paul A. Stone is CFO at IDEAYA Biosciences, Inc. (IDYA). They have made 2 open-market trades across 1 company since 2019, most recently 2023-08-29.
CIK 0001777511
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $2.5M since 2019, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IDYA | 9,303 | $305K |
Shares reported on the most recent Form 4, priced at the 2023-08-31 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IDYA | SELL · 10b5-1 | 2023-08-29 | 2023-08-31 | $28.87 | $144K | -1.1% | -12.4% | +5.7% |
| IDYA | SELL · 10b5-1 | 2023-08-21 | 2023-08-23 | $26.40 | $26K | +3.3% | -1.0% | +9.3% |
| IDYA | SELL · 10b5-1 | 2023-08-16 | 2023-08-18 | $26.38 | $207K | +10.6% | +9.6% | +13.8% |
| IDYA | SELL · 10b5-1 | 2023-08-09 | 2023-08-11 | $25.05 | $63K | +12.3% | +15.7% | +17.4% |
| IDYA | SELL | 2021-09-07 | 2021-09-09 | $27.42 | $69K | +1.8% | -2.7% | -11.3% |
| IDYA | SELL · 10b5-1 | 2020-06-17 | 2020-06-19 | $17.97 | $56K | -7.9% | -9.8% | -8.1% |
| IDYA | BUY | 2019-05-28 | 2019-05-28 | $10.00 | $2.5M | -9.2% | -13.1% | -46.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.